(1.02%) 5 099.96 points
(0.40%) 38 240 points
(2.03%) 15 928 points
(0.11%) $83.66
(-1.16%) $1.619
(0.30%) $2 349.60
(-0.43%) $27.52
(0.42%) $924.40
(0.32%) $0.935
(0.67%) $11.02
(0.13%) $0.800
(-0.07%) $92.11
Live Chart Being Loaded With Signals
Fresenius SE & Co. KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed...
Stats | |
---|---|
今日成交量 | 659 677 |
平均成交量 | 1.15M |
市值 | 15.33B |
EPS | €0 ( 2024-02-20 ) |
下一个收益日期 | ( €0.700 ) 2024-05-07 |
Last Dividend | €0.920 ( 2023-05-18 ) |
Next Dividend | €0 ( N/A ) |
P/E | 43.19 |
ATR14 | €0.0100 (0.04%) |
音量 相关性
Fresenius SE & Co KGaA 相关性
10 最正相关 |
---|
10 最负相关 |
---|
你知道吗?
相关性是描述两个变量之间关系的统计指标。它的取值范围为-1到1,其中-1表示完全负相关(一个变量增加,另一个变量减少),1表示完全正相关(一个变量增加,另一个变量也增加),0表示没有相关性(变量之间没有关系)。
相关性可用于分析任何两个变量之间的关系,而不仅仅是股票。它通常用于金融、经济学、心理学等领域。
Fresenius SE & Co KGaA 相关性 - 货币/商品
Fresenius SE & Co KGaA 财务报表
Annual | 2023 |
营收: | €22.30B |
毛利润: | €5.06B (22.68 %) |
EPS: | €-1.050 |
FY | 2023 |
营收: | €22.30B |
毛利润: | €5.06B (22.68 %) |
EPS: | €-1.050 |
FY | 2022 |
营收: | €40.84B |
毛利润: | €10.73B (26.26 %) |
EPS: | €2.44 |
FY | 2021 |
营收: | €37.52B |
毛利润: | €10.31B (27.48 %) |
EPS: | €3.26 |
Financial Reports:
No articles found.
Fresenius SE & Co KGaA Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0.920 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
€0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | €0.512 | 2000-06-09 |
Last Dividend | €0.920 | 2023-05-18 |
Next Dividend | €0 | N/A |
Payout Date | 0000-00-00 | |
Next Payout Date | N/A | |
# dividends | 25 | -- |
Total Paid Out | €12.51 | -- |
Avg. Dividend % Per Year | 0.00% | -- |
Score | 2.02 | -- |
Div. Sustainability Score | 6.12 | |
Div.Growth Potential Score | 2.35 | |
Div. Directional Score | 4.23 | -- |
Year | Amount | Yield |
---|
With a moderate Dividend Sustainability Score (DSS), the company may sustain its dividends, but continuous monitoring is advised for any financial shifts. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
UBK.DE | Ex Dividend Junior | 2023-06-30 | Sporadic | 0 | 0.00% | |
DWS.DE | Ex Dividend Knight | 2023-06-16 | Annually | 0 | 0.00% | |
NEM.DE | Ex Dividend Knight | 2023-05-24 | Annually | 0 | 0.00% | |
AAG.DE | Ex Dividend Junior | 2023-06-16 | Sporadic | 0 | 0.00% | |
XTP.F | Ex Dividend Junior | 2023-05-12 | Sporadic | 0 | 0.00% | |
FRE.DE | Ex Dividend Junior | 2023-05-18 | Annually | 0 | 0.00% | |
PHI1.DE | Ex Dividend Junior | 2023-05-11 | Annually | 0 | 0.00% | |
AWC.DE | Ex Dividend Junior | 2023-08-07 | Quarterly | 0 | 0.00% | |
HRPK.DE | Ex Dividend Junior | 2023-06-13 | Annually | 0 | 0.00% | |
SGF.DE | Ex Dividend Junior | 2023-06-29 | Annually | 0 | 0.00% |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | -0.0187 | 1.500 | -0.374 | -0.561 | [0 - 0.5] |
returnOnAssetsTTM | -0.0131 | 1.200 | -0.437 | -0.525 | [0 - 0.3] |
returnOnEquityTTM | -0.0298 | 1.500 | -1.443 | -2.16 | [0.1 - 1] |
payoutRatioTTM | -2.07 | -1.000 | -10.00 | 10.00 | [0 - 1] |
currentRatioTTM | 1.342 | 0.800 | 8.29 | 6.63 | [1 - 3] |
quickRatioTTM | 0.728 | 0.800 | -0.425 | -0.340 | [0.8 - 2.5] |
cashRatioTTM | 0.245 | 1.500 | 9.75 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.350 | -1.500 | 4.17 | -6.26 | [0 - 0.6] |
interestCoverageTTM | 2.53 | 1.000 | -0.174 | -0.174 | [3 - 30] |
operatingCashFlowPerShareTTM | 7.91 | 2.00 | 7.36 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 5.90 | 2.00 | 7.05 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.833 | -1.500 | 6.67 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.233 | 1.000 | 9.45 | 9.45 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.0554 | 1.000 | -0.892 | -0.892 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.281 | 1.000 | 9.55 | 9.55 | [0.2 - 2] |
assetTurnoverTTM | 0.702 | 0.800 | 8.65 | 6.92 | [0.5 - 2] |
Total Score | 6.12 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | -25.80 | 1.000 | -2.71 | 0 | [1 - 100] |
returnOnEquityTTM | -0.0298 | 2.50 | -0.927 | -2.16 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 5.90 | 2.00 | 8.03 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 3.38 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 7.91 | 2.00 | 7.36 | 10.00 | [0 - 30] |
payoutRatioTTM | -2.07 | 1.500 | -10.00 | 10.00 | [0 - 1] |
pegRatioTTM | 0.456 | 1.500 | -0.295 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.140 | 1.000 | 8.99 | 0 | [0.1 - 0.5] |
Total Score | 2.35 |
Fresenius SE & Co KGaA
Fresenius SE & Co. KGaA, a health care company, provides products and services for dialysis, hospitals, and outpatient medical care. It operates through four segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios, and Fresenius Vamed. The Fresenius Medical Care segment offers products and services for patients with chronic kidney failure. This segment provides dialyzers, hemodialysis machines, and related disposable products, as well as dialysis-related services. The Fresenius Kabi segment engages in the therapy and care of therapy and care ill patients. This segment offers IV drugs, including intravenously administered generic drugs for oncology, anesthetics, analgesics, anti-infectives, and critical care; parenteral and enteral nutrition products; infusion solutions and blood volume substitutes for infusion therapy; biosimilars, a biological medicine for autoimmune and oncology diseases; medical devices and disposal used to administer IV generic drugs, infusion therapies, and clinical nutrition products; and transfusion products for collection of blood components and corporeal therapies. The Fresenius Helios segment operates 90 hospitals, approximately 130 outpatient clinics, and 6 prevention centers in Germany; and 49 hospitals, 88 outpatient clinics, and approximately 300 risk prevention centers in Spain. This segment also provides services in the field of fertility treatments through 33 clinics and additional 39 sites across 10 countries on 3 continents. The Fresenius Vamed segment manages projects and offers services for hospitals and other health care facilities. This segment provides project development, planning, and turnkey construction services, as well as maintenance, technical management, and operational management services. The company was formerly known as Fresenius SE and changed its name to Fresenius SE & Co. KGaA in January 2011. Fresenius SE & Co. KGaA was founded in 1912 and is headquartered in Bad Homburg vor der Höhe, Germany.
关于 实时信号
此页面上呈现的实时信号有助于确定何时购买或出售NA. 信号具有高达1分钟的延迟;与所有市场信号一样,存在误差或错误的可能性。
实时交易信号不是绝对的,getagraph.com 对基于这些信号采取的任何行动概不负责,如《使用条款》中所述。这些信号是基于广泛的技术分析指标。